Skip to main content

Change in number of shares and votes in Saniona AB (publ)

PRESS RELEASENovember 29, 2019During November, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has increased due to exercising of options issued pursuant to the employee option program 2015/2019 that Saniona decided upon on the Annual General Meeting on 20 May 2015 for certain employees and key consultants in Saniona. As of November 29, 2019, the registered number of shares and votes in Saniona amounts to 28,412,519.For more information, please contactThomas Feldthus, EVP and CFO, Saniona. Mobile: +45 2210 9957, E-mail: tf@saniona.comThis information is such information as Saniona AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 8 a.m. CET on November 29, 2019.About SanionaSaniona is a research and development company focused on drugs for eating disorders and diseases of the central nervous system. The company has five programs in clinical development. Saniona intends to develop and commercialize treatments for orphan indications such as Prader-Willi syndrome and hypothalamic obesity on its own. The research is focused on ion channels and the company has a broad portfolio of research programs. Saniona has partnerships with Boehringer Ingelheim GmbH, Productos Medix, S.A de S.V and Cadent Therapeutics. Saniona is based in Copenhagen, Denmark, and the company’s shares are listed at Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com.Attachment20191129 – PR – Increase number of shares – UK

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.